Tamiflu
Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead
September 30, 2020Research and Development Roche, Tamiflu
A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …
Roche’s Xofluza proves non-inferior to Tamiflu in children with flu
July 3, 2019Research and Development Roche, Tamiflu, flu, pharma
Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …
Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?
July 17, 2018Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma
Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …
New flu med can destroy influenza virus in one day
February 13, 2018Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical
Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …
First generic copy of Roche’s Tamiflu hits US market
December 12, 2016Sales and Marketing Alvogen, Roche, Tamiflu
Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …
Government spending on Tamfilu is justified
January 30, 2015Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency
The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …
NICE seeks more trial data from pharma
September 10, 2014Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency
NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …
NICE to look again at Tamiflu after data saga
April 11, 2014Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu
The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …
Tamiflu stockpiling ‘unjustifiable’ and wasted £424m
April 10, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials
Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
GMP issues affect Mircera, Xenical production at Roche plant
January 31, 2012Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical
Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …
BMJ blasts Roche for withholding Tamiflu data
January 18, 2012Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO
Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …
Tamiflu windfall helps Roche to bumper sales growth
October 15, 2009Sales and Marketing Roche, Tamiflu
Roche has raised its sales growth prediction for 2009 on the back of a strong third quarter and record sales …
Latest content
FibroFind appoints Lee Borthwick as CEO
